Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Baxter International Inc (BAX)

Baxter International Inc (BAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Baxter International Inc One Baxter Parkway DF2-1W Deerfield IL 60015 USA

P: 224-948-2000 F: 877-334-2298

Description:

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.

Key Statistics

Overview:

Market Capitalization, $K 38,968,776
Shares Outstanding, K 505,104
Annual Sales, $ 11,673 M
Annual Net Income, $ 1,102 M
Last Quarter Sales, $ 3,181 M
Last Quarter Net Income, $ 168,000 K
60-Month Beta 0.66
% of Insider Shareholders 0.13%
% of Institutional Shareholders 83.07%
Float, K 504,447
% Float 99.87%

Growth:

1-Year Return -11.19%
3-Year Return 10.93%
5-Year Return 88.78%
5-Year Revenue Growth 17.10%
5-Year Earnings Growth 123.91%
5-Year Dividend Growth -97.11%

Per-Share Information:

Most Recent Earnings 0.80 on 02/04/21
Next Earnings Date N/A
Earnings Per Share ttm 3.09
EPS Growth vs. Prev Qtr -3.61%
EPS Growth vs. Prev Year -17.53%
Annual Dividend Rate, $ 0.98
Annual Dividend Yield 1.27%
Most Recent Dividend 0.245 on 02/25/21
Next Ex-Dividends Date 02/25/21
Dividend Payable Date 04/01/21
Dividend Payout Ratio 30.36
Most Recent Split 46-25 on 07/01/15

BAX Ratios

Ratio
Price/Earnings ttm 25.14
Price/Earnings forward 25.44
Price/Earnings to Growth 2.48
Return-on-Equity % 19.23%
Return-on-Assets % 8.12%
Profit Margin % 9.44
Net Margin % 16.27
Debt/Equity 0.67
Price/Sales 3.36
Price/Cash Flow 16.10
Price/Book 4.50
Book Value/Share 17.28
Interest Coverage 10.64

BAX Dividends

Date Value
02/25/21 $0.2450
12/03/20 $0.2450
08/28/20 $0.2450
06/04/20 $0.2450
02/27/20 $0.2200
12/05/19 $0.2200
08/29/19 $0.2200
06/06/19 $0.2200
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar